U.S. stock night trading opened with fluctuations: Coincheck Group BV fell 4.69% in night trading; Barclays rose 3.77% in night trading

U.S. Stock Night Market Opening Movements Coincheck Group BV fell 4.69% in the night market. Based on recent key news: On December 2, Coincheck Group BV released unaudited preliminary financial data, raising concerns in the market about its financial stability. The information disclosed through the EDGAR system indicated that the data might be updated, increasing uncertainty and affecting investor confidence, leading to a decline in stock price. On December 3, the market expressed concerns about the authenticity of Coincheck Group BV's financial data. Due to the data being unaudited and potentially subject to updates, investors questioned the company's financial transparency, further exacerbating stock price volatility. No other significant news recently. The market remains focused on financial transparency. Barclays rose 3.77% in the night market. Based on recent key news: On December 2, the Bank of England announced the results of stress tests, with Barclays successfully passing the tests, demonstrating its capital adequacy, which boosted market confidence and drove up the stock price. Source: Bloomberg On December 3, the Bank of England lowered capital requirements for banks, reducing Barclays' capital ratio from 14% to 13%, which is expected to promote lending and shareholder returns, further supporting the rise in stock price. Source: J.P. Morgan On December 1, Barclays economists predicted that the Bank of Japan might raise interest rates in December, enhancing market confidence in Japan's economic growth, indirectly benefiting Barclays. Source: Jin10 Data European banking sector performs strongly, with significant capital inflows. Top Gainers in the U.S. Stock Night Market Cantor Equity Partners rose 15.93% in the night market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. Davis Commodities rose 12.24% in the night market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. Fibrobiologics rose 11.85% in the night market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation